Adenomyoepithelioma of the breast with associated atypical lobular hyperplasia: a previously unrecognized association with management implications

Zhang, Shuang; Huo, Lei; Arribas, Elsa; Middleton, Lavinia P.

doi:10.1016/j.anndiagpath.2014.11.002

Search citation statements

Order By: Relevance

Paper Sections

Select...

Adenomyoepithelioma and Its Malignant Counterpart1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

2021

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Conventional ductal or lobular carcinoma in situ can be associated with AME, but outside the AME neoplastic mass [43][44][45]. These latter cases should not be identified as MIS-AME.…”

Section: Adenomyoepithelioma and Its Malignant Counterpartmentioning

confidence: 99%

Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses

et al. 2021

View full text Add to dashboard Cite

Triple-negative breast carcinomas constitute a wide spectrum of lesions, mostly being highly aggressive. Nevertheless, some special histologic subtypes can have low malignant potential. The purpose of the present paper is to review diagnostic criteria and prognostic parameters of breast neoplasms of special histotypes. Specifically, adenoid cystic carcinoma, adenomyoepithelioma, acinic cell carcinoma, mucoepidermoid carcinoma, tall cell carcinoma with reverse polarity, and secretory carcinoma will be discussed. For each tumour, definition and morphological and molecular features, together with prognostic parameters, will be presented. Paradigmatic cases will be illustrated.

show abstract

“…Conventional ductal or lobular carcinoma in situ can be associated with AME, but outside the AME neoplastic mass [43][44][45]. These latter cases should not be identified as MIS-AME.…”

Section: Adenomyoepithelioma and Its Malignant Counterpartmentioning

confidence: 99%